Clinical Trial: Clinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye Drops
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Wet Age Related Macular Degeneration
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Administration of SCAI-005 Ophthalmic Solutio
Brief Summary:
To assess the single-dose and multiple-dose pharmacokinetics (PK), safety and tolerability of SCAI-005 eyedrops(axitinib) in healthy volunteers
Read more